Regeneron Pharmaceuticals

target reach ladder climb meet win beat competition
Biotech

Apogee data drive hype as threat to Lilly, Sanofi becomes clear

Analysts doubled their peak sales forecast to $5.2 billion in the belief zumilokibart will become the first-line treatment for most eczema patients.
Nick Paul Taylor Mar 23, 2026 9:00am
Female leg stepping on weigh scales with measuring tape

Regeneron's obesity drug shows Zepbound-like efficacy in phase 3

Mar 9, 2026 8:25am
saker falcon

Ipsen fails to land pivotal rare disease trial

Dec 19, 2025 3:37pm
Graphic of two hands shaking under a red and purple light

Regeneron inks $150M pact with gene writer Tessera

Dec 1, 2025 11:12am
Two businessmen pushing giant puzzle pieces together as the sun sets behind them

Regeneron pledges $1B+ for ModeX multispecific antibodies

Oct 29, 2025 11:04am
ZigZag zigging zagging

Zag Bio emerges with $80M funding for Tregs diabetes candidate

Oct 28, 2025 7:00am